4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-038451
Director sold 19,565 shares at $15.14 ($296,269)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHIFF ANDREW N Director | 2022-06-17 | Sale | −19,565 | $15.14 | $296,269 | 0 | D |
| Open-market sales · 19,565 sh · avg $15.14 · $296,269 | |||||||
Loading xslF345X03/doc4.xml…